isoproterenol has been researched along with zofenopril in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Graeff, PA; de Langen, CD; Pinto, YM; van Gilst, WH; van Wijngaarden, J; Wesseling, H | 1 |
| Bigioni, M; Evangelista, S; Goso, C; Maggi, CA; Manzini, S; Sacco, G | 1 |
2 other study(ies) available for isoproterenol and zofenopril
| Article | Year |
|---|---|
Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Enalapril; Heart; Heart Rate; Isoproterenol; Male; Myocardial Infarction; Myocardium; Rats; Rats, Inbred Strains | 1991 |
Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antineoplastic Agents; Body Weight; Captopril; Cardiotonic Agents; Doxorubicin; Drug Therapy, Combination; Electrocardiography; Female; Heart; Hemodynamics; Isoproterenol; Male; Mice; Mice, Nude; Organ Size; Ovarian Neoplasms; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |